 Cortexyme, Inc. Nasdaq: CRTX, a clinical stage biopharmaceutical company pioneering potential therapeutics for Alzheimers and other degenerative diseases, today announced Casey Lynch, the companys chief executive officer, chair, and co-founder, will present at the following two investor conferences in August 2020: 